Merck Scores Patent Extension Win In EU High Court
The European Union's highest court handed Merck & Co. Inc. a victory Thursday in its bid to win extended patent protection for a diabetes drug, ruling drugmakers should receive extensions for...To view the full article, register now.
Already a subscriber? Click here to view full article